Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-01

Clinical Trial Update: Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen in Newly Diagnosed Elderly AML [Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 2 study of mitoxantrone hydrochloride liposome with cytarabine and venetoclax in newly diagnosed elderly acute myeloid leukemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYTARABINE (CYTARABINE)
  • Mitoxantrone hydrochloride liposome (Mitoxantrone hydrochloride liposome)
  • Venetoclax (venetoclax)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING